If you're looking for a platform to accelerate clinical trials and get new treatments to patients faster, Medidata is a good option. Medidata's suite of products for clinical research includes AI-powered insights, patient-centric tools and data management. Key products include Clinical Data Studio, Rave EDC for electronic data capture and Medidata AI for advanced analytics. The result is a robust platform for managing trials. With more than 25 years of experience and involvement in 65% of FDA-approved novel drug approvals since 2015, Medidata's platform has a proven track record of speeding up the clinical trial process to bring new treatments to market.
Another good option is Verily Viewpoint, an integrated suite of tools and services for clinical research. It includes modules like Recruit for participant recruitment, Workbench for secure and scalable analytics, Site CTMS for digitizing protocols into workflows, and Longitudinal, Participant-Centric Registries for integrating real-world data. These modules are designed to increase research efficiency and quality, enabling the collection of higher quality and more comprehensive data to accelerate trials and make them more patient centered.
For a more general precision health approach, check out Verily. Verily offers data, evidence and software solutions to accelerate clinical research and personalized care. Its suite of tools, including Onduo for virtual care management and Viewpoint for clinical research, use AI and data science to improve the efficiency and accessibility of healthcare. By integrating research and care, Verily is helping to accelerate clinical research and patient care.
Last, Tempus offers an AI-powered precision medicine platform that offers insights to improve cancer treatment. It includes tools like ONE for patient insights, NEXT for care gap identification, LENS for real-world data analysis, and ALGOS for algorithmic models connected to assays. Tempus helps doctors make informed treatment decisions and pharmaceutical companies develop drugs, making it a good option for accelerating clinical trials and personalized patient care.